• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

POSCO BioVentures

edit

POSCO BioVentures’ primary investment focus is on companies with novel, proprietary bio-molecules. POSCO BioVentures expects that 70% of its investments will be in companies focused on novel proprietary bio-molecules, with the balance of the investments in other enabling technologies.

Milestones

edit

• 
  POSCO BioVentures invested in TransMedics. (3/30/10)
  Posted 3/5/10 at 1:53pm via onbiovc.com
• 
  POSCO BioVentures invested in Pulmonx. (3/8/10)
  Posted 3/8/10 at 2:54pm via onbiovc.com
• 
  POSCO BioVentures invested in Accera. (6/1/04)
  Posted 2/23/10 at 5:35pm via sec.gov
• 
  POSCO BioVentures invested in TransMedics. (1/27/04)
  Posted 12/8/09 at 6:06pm via transmedics.com
• 
  POSCO BioVentures invested in TransMedics. (4/13/07)
  Posted 12/8/09 at 6:06pm via transmedics.com
• 
  POSCO BioVentures invested in ProteinSimple. (1/1/06)
  Posted 11/16/09 at 2:54pm via bio-medicine.org
• 
  POSCO BioVentures invested in Accera. (11/12/08)
  Posted 6/23/09 at 12:01pm via fiercebiotech.com

Investments

Videos

Sources

1. TransMedics, Inc.: Series E $36M (onbiovc.com) [edit]
2. Pulmonx, Inc.: Series C $32M (onbiovc.com) [edit]
3. Accera raises $35M (fiercebiotech.com) [edit]
4. TransMedics (transmedics.com) [edit]
5. Bio-Medicine (bio-medicine.org) [edit]
6. SEC D (sec.gov) [edit]
7. TransMedics (transmedics.com) [edit]